All Relations between dopaminergic and basal ganglia

Publication Sentence Publish Date Extraction Date Species
S P Sivam, J E Kraus. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA. Journal of neurochemistry. vol 59. issue 6. 1992-12-22. PMID:1279124. tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance p-encoding mrnas, and substance p receptor mrna. 1992-12-22 2023-08-11 Not clear
J Hierholzer, M Cordes, L Schelosky, G Barzen, W Poewe, H Henkes, U Keske, R Horowski, R Feli. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. vol 157. issue 4. 1992-11-25. PMID:1391843. drug-native patients showed a significantly higher ibzm binding in the basal ganglia as compared to patients on specific dopaminergic medication. 1992-11-25 2023-08-11 Not clear
A M Allen, D P MacGregor, S Y Chai, G A Donnan, S Kaczmarczyk, K Richardson, R Kalnins, J Ireton, F A Mendelsoh. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Annals of neurology. vol 32. issue 3. 1992-11-13. PMID:1416803. angiotensin ii receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. 1992-11-13 2023-08-11 human
C R Gerfe. The neostriatal mosaic: multiple levels of compartmental organization. Journal of neural transmission. Supplementum. vol 36. 1992-10-22. PMID:1527520. insights into the role of dopaminergic function within the basal ganglia may have direct relevance to the development of treatments for schizophrenia. 1992-10-22 2023-08-11 Not clear
L W Fitzgerald, K J Miller, A K Ratty, S D Glick, M Teitler, K W Gros. Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant. Brain research. vol 580. issue 1-2. 1992-09-23. PMID:1354555. this unique mutant provides a novel genetic model of basal ganglia dysfunction, and may be useful in studying aspects of neuropsychiatric disorders associated with dopaminergic abnormalities. 1992-09-23 2023-08-11 mouse
A Reiner, R G Northcut. An immunohistochemical study of the telencephalon of the senegal bichir (Polypterus senegalus). The Journal of comparative neurology. vol 319. issue 3. 1992-07-16. PMID:1351063. several features of the labeling patterns obtained suggested that the dorsal and ventral subdivisions of the area ventralis are homologous as a field to the basal ganglia and septum plus other basal telencephalic regions of land vertebrates, sharks and lungfish: 1) an abundance of sp+, npy+, and enk+ fibers; 2) an abundance of th+ fibers, possibly of posterior tubercle/tegmental origin; 3) the presence of an sp+ fiber bundle that appeared to descend from basal telencephalic levels and terminate in the posterior tubercle/tegmentum, which contain th+ (possibly dopaminergic) neurons; and 4) an abundance of 5ht+ fibers, presumably of posterior tubercle/tegmental origin. 1992-07-16 2023-08-11 Not clear
R L Watts, A S Mandi. The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. Neurologic clinics. vol 10. issue 2. 1992-06-17. PMID:1584184. the characteristic motor deficits of parkinsonism result from dysfunction of the nigrostriatal dopaminergic system of the basal ganglia. 1992-06-17 2023-08-11 Not clear
M J Steiger, M Pires, F Scaravilli, N P Quinn, C D Marsde. Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration. Movement disorders : official journal of the Movement Disorder Society. vol 7. issue 1. 1992-05-04. PMID:1557069. dyskinesias associated with dopaminergic treatment in idiopathic parkinson's disease (pd) can be indistinguishable from those arising spontaneously in other conditions involving degeneration of, or damage to, the basal ganglia. 1992-05-04 2023-08-11 Not clear
F Mennicken, M Savasta, R Peretti-Renucci, C Feuerstei. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935. Journal of neural transmission. General section. vol 87. issue 1. 1992-03-30. PMID:1346964. a dopaminergic denervation caused a complete loss of [3h]gbr 12935 in basal ganglia ipsilateral to the lesion. 1992-03-30 2023-08-11 rat
B K Lipska, G E Jaskiw, F Karoum, I Phillips, J E Kleinman, D R Weinberge. Dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia. Pharmacology, biochemistry, and behavior. vol 40. issue 1. 1992-03-10. PMID:1664108. dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia. 1992-03-10 2023-08-11 rat
S Holemans, F Javoy, Y Agid, E C Laterre, J M Maloteau. [3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy. Brain research. vol 565. issue 1. 1992-02-28. PMID:1837752. the interactions existing between glutamatergic and dopaminergic systems, notably in the basal ganglia, suggest that glutamatergic antagonists may have therapeutic interest in extrapyramidal disorders characterized by impaired dopaminergic transmission. 1992-02-28 2023-08-11 Not clear
P A Löschmann, K W Lange, M Kunow, K J Rettig, P Jähnig, T Honoré, L Turski, H Wachtel, P Jenner, C D Marsde. Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section. vol 3. issue 3. 1992-01-07. PMID:1835581. degeneration of dopaminergic nigrostriatal neurons in parkinson's disease results in an overactivity of excitatory glutamatergic projections from the subthalamic nucleus to the output nuclei of the basal ganglia resulting in rigidity and akinesia. 1992-01-07 2023-08-11 rat
H A Robertson, M L Paul, R Moratalla, A M Graybie. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 18. issue 3 Suppl. 1991-12-19. PMID:1682022. expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. 1991-12-19 2023-08-11 Not clear
L J Martin, D M Spicer, M H Lewis, J P Gluck, L C Cor. Social deprivation of infant rhesus monkeys alters the chemoarchitecture of the brain: I. Subcortical regions. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 11. issue 11. 1991-12-12. PMID:1682426. abnormal motor and psychosocial behaviors resulting from this form of social/sensory deprivation may result from alterations in peptidergic and dopaminergic systems within the basal ganglia. 1991-12-12 2023-08-11 human
S P Sivam, J E Kraus. The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion. Brain research. vol 536. issue 1-2. 1991-05-21. PMID:1707718. the adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion. 1991-05-21 2023-08-11 rat
S P Sivam, J E Kraus. The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion. Brain research. vol 536. issue 1-2. 1991-05-21. PMID:1707718. the results indicate that the normal development of enkephalin and tachykinin and 5-ht systems of basal ganglia are dependent on the availability of da and/or the integrity of the nigrostriatal dopaminergic neurons. 1991-05-21 2023-08-11 rat
S Usui, H Fukuda, O Hikosak. [Spontaneous saccades in MPTP-induced hemi-parkinsonian monkeys]. Rinsho shinkeigaku = Clinical neurology. vol 30. issue 11. 1991-05-17. PMID:2085922. these results show that deficiency of nigrostriatal dopaminergic system affects the neural mechanism of saccadic eye movements in the basal ganglia. 1991-05-17 2023-08-11 monkey
Y Iwakawa, M Shimohira, S Kondo, Y Sat. [Neurophysiological studies on group A xeroderma pigmentosum in early childhood]. No to hattatsu = Brain and development. vol 22. issue 6. 1991-02-07. PMID:2175631. because the body movements during sleep are controlled by the nigrostriatal dopaminergic system, present data indicate that the basal ganglia might be one of the earliest degenerative systems in the cns. 1991-02-07 2023-08-11 human
C R Gerfen, T M Engber, L C Mahan, Z Susel, T N Chase, F J Monsma, D R Sible. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (New York, N.Y.). vol 250. issue 4986. 1991-01-22. PMID:2147780. the striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. 1991-01-22 2023-08-11 rat
A Parent, B Lavoie, Y Smith, P Bédar. The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys. Advances in neurology. vol 53. 1990-12-13. PMID:1978512. thus, in addition to their potent influence at striatal levels, the midbrain dopaminergic neurons may directly modulate the activity of basal ganglia output neurons at pallidal levels. 1990-12-13 2023-08-11 monkey